CHENGZHI(000990)2024-10-24 10:02Financial Performance - Operating revenue for Q3 2024 was ¥2,576,528,671.05, a decrease of 25.64% year-over-year[2] - Net profit attributable to shareholders was ¥31,322,492.13, down 81.23% compared to the same period last year[2] - Net profit excluding non-recurring gains and losses was ¥23,677,722.08, a decline of 85.90% year-over-year[2] - Basic earnings per share for Q3 2024 was ¥0.0258, down 81.21% from the previous year[2] - Total operating revenue for Q3 2024 was ¥8,237,562,153.58, a decrease of 17.7% compared to ¥10,016,817,075.31 in Q3 2023[13] - Total operating costs for Q3 2024 were ¥7,744,903,559.52, down from ¥9,619,387,978.81 in the same period last year, reflecting a reduction of 19.5%[13] - The net profit for Q3 2024 was CNY 301,992,109.07, an increase of 36.2% compared to CNY 221,655,203.65 in the same period last year[14] - The total profit amounted to CNY 422,709,695.85, up from CNY 285,740,226.37, reflecting a growth of 48.0% year-over-year[14] - Operating profit reached CNY 423,827,439.50, compared to CNY 301,142,116.57 in Q3 2023, marking a 40.7% increase[14] - The total comprehensive income for the period was CNY 301,695,971.89, compared to CNY 222,108,415.82 in Q3 2023, indicating a growth of 35.8%[14] - Earnings per share (EPS) for the quarter was CNY 0.1798, up from CNY 0.1076 in the same period last year[14] Cash Flow and Investments - The company reported a net cash flow from operating activities of ¥1,161,086,778.30, an increase of 26.94% year-to-date[2] - Cash inflow from investment activities increased by 47.46% to ¥4,428,934,266.75, primarily due to an increase in the redemption of current financial investments[6] - Cash outflow from investment activities surged by 95.58% to ¥6,296,469,045.15, mainly due to increased project investments and current financial investments[6] - Net cash flow from investment activities was negative at ¥-1,867,534,778.40, a significant increase of 764.59% compared to ¥-216,001,880.38 last year[6] - Cash inflow from financing activities rose by 30.80% to ¥4,181,552,851.31, driven by increased issuance of corporate bonds and bank loans[6] - Net cash flow from financing activities increased by 494.65% to ¥398,313,851.52, attributed to new loans and the issuance of corporate medium-term notes[6] - Cash flow from operating activities generated CNY 1,161,086,778.30, an increase of 27.0% from CNY 914,641,835.56 in the previous year[15] - Cash flow from investment activities showed a net outflow of CNY 1,867,534,778.40, worsening from a net outflow of CNY 216,001,880.38 in the same quarter last year[15] - Cash flow from financing activities resulted in a net inflow of CNY 398,313,851.52, compared to a net outflow of CNY 100,928,511.86 in Q3 2023[15] Assets and Liabilities - Total assets increased to ¥26,804,237,087.91, representing a growth of 4.12% from the end of the previous year[2] - The company’s total liabilities increased by 46.86% due to increased financing activities[4] - The company’s long-term borrowings rose by 74.54% to ¥1,150,559,674.25, primarily due to new bank loans[4] - The total current assets increased to ¥7,004,422,400.70 from ¥6,362,213,631.06, representing a growth of about 10.1%[10] - Total liabilities reached ¥8,093,658,490.36 in Q3 2024, an increase from ¥7,280,190,487.54 in Q3 2023, representing a rise of 11.1%[12] - The company's total equity amounted to ¥18,710,578,597.55 in Q3 2024, up from ¥18,463,185,577.11 in Q3 2023, reflecting an increase of 1.3%[12] - Non-current assets totaled ¥19,799,814,687.21 as of Q3 2024, compared to ¥19,381,162,433.59 at the end of Q3 2023, indicating a growth of 2.2%[12] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 44,474[7] - The largest shareholder, Chengzhi Kairun Holdings, holds 30.83% of the shares, totaling 374,650,564 shares[7] - The second-largest shareholder, Tianfu Qingyuan Holdings, owns 15.77% of the shares, amounting to 191,677,639 shares[7] Projects and Developments - The company has completed the construction of the new material integrated propylene value chain project with a total investment of ¥1.05 billion, and is currently preparing for trial production[9] - The company is in the process of establishing a health insurance company with a planned registered capital of ¥1 billion, although there has been no progress reported as of this period[8] - The company has initiated the IPO preparation for its subsidiary, Chengzhi Yonghua, with ongoing due diligence work[8] - The company has invested approximately ¥350 million in the high-performance liquid crystal materials industry upgrade project, with the feasibility study report completed[9] - The company has received a refund of ¥2,399,200 related to the cancellation of the liquid crystal materials project, with ¥2 million already paid[8] - The company has completed the construction of the multifunctional workshop and raw material workshop project in Yingtan, with an expected total investment of ¥350 million[9] - The company is negotiating a repayment plan with Wansheng Bio, with an agreement reached for installment payments totaling ¥133,178,783.74 plus penalties[9] - The company has completed the construction of the POE project and ultra-high molecular weight polyethylene project, with necessary permits obtained[8] Cash and Cash Equivalents - Cash and cash equivalents decreased by 41.71% to ¥62,871,694.00 from ¥107,863,096.46 year-on-year[6] - The company's cash and cash equivalents decreased to ¥2,016,424,931.27 from ¥2,407,480,358.55, reflecting a decline of approximately 16.2%[10] - The company's cash and cash equivalents at the end of the period stood at CNY 1,951,414,527.38, slightly up from CNY 1,910,448,084.48 at the end of Q3 2023[16] - The cash and cash equivalents decreased to ¥3,003,748,849.16 in Q3 2024 from ¥2,990,427,708.27 in Q3 2023, showing a slight increase of 0.7%[11]